World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
34840
World Ranking
12088
National Ranking
6201

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

David M. Nanus is affiliated with Cornell University in the United States. Their research primarily focuses on cancer, with a significant emphasis on prostate cancer treatment and research. The scientist's work encompasses various related fields such as medicine, biochemistry, genetics, and molecular biology.

Their recent research outputs include studies published between 2020 and 2021, highlighting advances in understanding prostate cancer and its treatment modalities. Notable papers include:

  • Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer, 2020, Journal of Clinical Investigation
  • A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer, 2020, Clinical Cancer Research
  • Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer, 2021, Nature Communications
  • Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer, 2020, JCO Precision Oncology
  • SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy, 2020, Molecular Cancer Therapeutics

David M. Nanus collaborates regularly with several frequent co-authors, including:

  • Scott T. Tagawa
  • Cora N. Sternberg
  • Ana M. Molina
  • Jones T. Nauseef
  • Joseph R. Osborne

The scientist's publications appear predominantly in high-impact academic venues such as:

  • Journal of Clinical Oncology
  • Cancer Research
  • The Journal of Urology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of Oncology

Their work covers a range of subfields including pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, cancer research, oncology, and molecular biology. Major research topics include:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Prostate Cancer Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Cancer, Lipids, and Metabolism

David M. Nanus has been recognized as a member of the Association of American Physicians, reflecting professional acknowledgment within their field.

Best Publications

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Renal-cell carcinoma.

    Robert J. Motzer;Neil H. Bander;David M. Nanus

  • Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

    Himisha Beltran;Himisha Beltran;Davide Prandi;Juan Miguel Mosquera;Juan Miguel Mosquera;Matteo Benelli

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

    Himisha Beltran;David S. Rickman;Kyung Park;Sung Suk Chae

  • Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

    Neil H. Bander;Matthew Ivan Milowsky;David M. Nanus;Lale Kostakoglu

  • Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity

    Himisha Beltran;Roman Yelensky;Garrett M. Frampton;Kyung Park

  • Erratum: Integrative Clinical Genomics of Advanced Prostate Cancer

    Dan Robinson;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/neu–Positive Urothelial Carcinoma: Results of a Multicenter Phase II National Cancer Institute Trial

    Maha H.A. Hussain;Gary R. MacVicar;Daniel P. Petrylak;Rodney L. Dunn

  • Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

    Jason P. Gleghorn;Erica D. Pratt;Denise Denning;He Liu

  • Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer

    Medha S Darshan;Matthew S Loftus;Maria Thadani-Mulero;Ben P Levy

  • Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

    Scott T. Tagawa;Matthew I. Milowsky;Michael Morris;Shankar Vallabhajosula

  • Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.

    Papandreou Cn;Usmani B;Geng Y;Bogenrieder T

  • Phase I Trial of Yttrium-90--Labeled Anti--Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

    Matthew I. Milowsky;David M. Nanus;Lale Kostakoglu;Shankar Vallabhajosula

  • Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression.

    Guenther A. Gastl;John S. Abrams;David M. Nanus;Rianne Oosterkamp

  • Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma

    Robert J. Motzer;Barbara A. Murphy;Jennifer Bacik;Lawrence H. Schwartz

  • Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.

    D O Hardy;H I Scher;T Bogenreider;P Sabbatini

  • Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.

    Kevin A. David;Matthew Ivan Milowsky;Jamie Ritchey;Peter R. Carroll

  • Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors

    Matthew Ivan Milowsky;David M. Nanus;Lale Kostakoglu;Christine E. Sheehan

  • Molecular characterization of neuroendocrine prostate cancer (NEPC) and identification of new drug targets.

    H. Beltran;D. Rickman;K. Park;A. Sboner

Frequent Co-Authors

Himisha Beltran
Himisha Beltran Harvard University
Neil H. Bander
Neil H. Bander Cornell University
Mark A. Rubin
Mark A. Rubin University of Bern
Juan Miguel Mosquera
Juan Miguel Mosquera Cornell University
Stanley J. Goldsmith
Stanley J. Goldsmith Cornell University
Paul J. Christos
Paul J. Christos Cornell University
Andrea Sboner
Andrea Sboner Cornell University
Olivier Elemento
Olivier Elemento Cornell University
Lorraine J. Gudas
Lorraine J. Gudas Cornell University
Francesca Demichelis
Francesca Demichelis University of Trento

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a range of online degrees and career options beyond the traditional MD. For nurses seeking advanced roles, the best online bsn to dnp programs provide flexible pathways to earn a Doctor of Nursing Practice (DNP) degree, combining clinical skills with leadership training.

If you're interested in pharmaceuticals, pharmacy school online options make it possible to start or advance your pharmacy career with accredited, remote study. For those drawn to healthcare technology and data, an online health information management degree can lead to roles managing patient records and healthcare information systems.

Entry-level programs like medical billing and coding online courses cost comparatively less and offer a fast track to jobs in healthcare administration, all from the comfort of your home. These online pathways provide flexibility, affordability, and a variety of opportunities to build your healthcare career without relocating or pausing your current commitments.

Best Scientists Citing David M. Nanus

Trending Scientists